Twist Bioscience Corp Income Statement
TWST / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 9 fiscal years. All figures from audited SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | $185.6M | $179.6M | $155.4M | $119.3M | $80.6M | $61.4M | $47.4M | $32.2M | $24.0M |
| SG&A Expense | $247.0M | $218.4M | $189.7M | $212.9M | $135.9M | $103.3M | $80.1M | $43.5M | $26.1M |
| R&D Expense | $80.3M | $90.9M | $106.9M | $120.3M | $69.1M | $43.0M | $35.7M | $20.3M | $19.2M |
| Operating Income | -$136.3M | -$220.8M | -$217.2M | -$234.8M | -$152.7M | -$140.1M | -$108.8M | -$70.6M | -$58.5M |
| Interest Expense | - | - | $5.0K | $80.0K | $367.0K | $787.0K | $1.3M | $1.3M | $905.0K |
| Income Tax | $719.0K | $560.0K | $1.2M | -$10.4M | -$1.9M | $382.0K | $292.0K | $242.0K | $280.0K |
| Net Income | -$77.7M | -$208.7M | -$204.6M | -$217.9M | -$152.1M | -$139.9M | -$107.7M | -$71.2M | -$59.3M |
| EPS (Basic) | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | - | - | - |
| EPS (Diluted) | -$1.30 | -$3.60 | -$3.60 | -$4.04 | -$3.15 | -$3.57 | - | - | - |
| Shares Outstanding | 59.8M | 58.0M | 56.9M | 53.9M | 48.3M | 39.2M | 27.5M | 2.8K | 2.4B |